e-learning
resources
ERJ
2022
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Applications of CRISPR technology to lung cancer research
Anabel Sorolla, Eva Parisi, Maria Alba Sorolla, Marta Marqués, José M. Porcel
Source:
Eur Respir J, 59 (1) 2102610; 10.1183/13993003.02610-2021
Journal Issue:
January
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Anabel Sorolla, Eva Parisi, Maria Alba Sorolla, Marta Marqués, José M. Porcel. Applications of CRISPR technology to lung cancer research. Eur Respir J, 59 (1) 2102610; 10.1183/13993003.02610-2021
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications
Source: Eur Respir J 2009; 33: 489-506
Year: 2009
Evolution in the diagnostic approach to lung cancer
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Year: 2021
Radiomics in lung cancer: progress and challenges
Source: Virtual Congress 2021 – Chinese programme 2021
Year: 2021
Screening for lung cancer - Opportunities and challenges
Source: Short video statement 2020
Year: 2020
Exploring the 24h-effect of targeted therapies in non-small cell lung cancer from exon array blood profiling using dually constrained correspondence analysis
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015
Modern molecular lung cancer diagnostics – how to use and interpret it wisely
Source: International Congress 2018 – PG11 Modern approaches in lung cancer diagnostics and therapy
Year: 2018
Progress and applications of mouse models for human lung cancer
Source: Eur Respir J 2010; 35: 426-443
Year: 2010
Novel approaches in metastasised non-small cell lung cancer with a special focus on modern systemic therapies
Source: International Congress 2019 – State of the art session: Thoracic oncology
Year: 2019
PG11 Modern approaches in lung cancer diagnostics and therapy
Source: Paris 2018 - Educational material
Year: 2018
Complexity of diagnostics of complicated lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 39s
Year: 2004
Biomarkers in early-detection of lung cancer: current concepts
Source: Virtual Congress 2021 – Biomarkers in early-detection of lung cancer: current concepts
Year: 2021
Precision medicine for lung cancer: new targeted treatments
Source: International Congress 2017 – Precision medicine approaches in lung cancer
Year: 2017
Exploiting metabolomic approaches to aid in the diagnosis of lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016
How to build a lung: latest advances and emerging themes in lung bioengineering
Source: Eur Respir J, 52 (1) 1601355; 10.1183/13993003.01355-2016
Year: 2018
The ALA/ATS implementation guide on lung cancer screening
Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance!
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept